XML 69 R35.htm IDEA: XBRL DOCUMENT v2.4.1.9
Acquisitions Acquisitions (Tables)
12 Months Ended
Dec. 31, 2014
Business Acquisition [Line Items]  
Business Acquisition, Pro Forma Information
The following unaudited pro forma financial information reflects the consolidated statements of income of the Company for the years ended December 31, 2014 as if the acquisition of Tenaxis had occurred as of January 1, 2013, and as if the 2013 acquisitions had occurred as of January 1, 2012.
 
 
 
 
 
 
 
Year Ended December 31,
 
 
2014
 
2013
 
 
(in thousands, except per share amounts)
Net revenue
 
$
724,599

 
$
695,473

Net loss
 
$
(35,023
)
 
$
(32,743
)
Basic loss per common share
 
$
(0.54
)
 
$
(0.56
)
Diluted loss per common share
 
$
(0.54
)
 
$
(0.56
)
Incline Therapeutics, Inc. [Member]  
Business Acquisition [Line Items]  
Schedule of Business Acquisitions, by Acquisition
Total purchase price is summarized as follows:
 
 
(in thousands)
Upfront cash consideration
 
$
186,699

Fair value of contingent purchase price
 
87,200

Total purchase price
 
$
273,899

 
 
 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
Below is a summary which details the allocation of assets acquired and liabilities assumed as a result of this acquisition:

 
 
 
Assets Acquired:
 
(in thousands)
Cash and cash equivalents
 
$
1,563

Prepaid expenses and other current assets
 
624

Fixed assets, net
 
12,577

In-process research and development
 
250,000

Goodwill
 
102,613

Other assets
 
34

Total Assets
 
$
367,411

Liabilities Assumed:
 
 
Accrued expenses
 
$
1,413

Contingent purchase price
 
87,200

Deferred tax liabilities
 
92,099

Total Liabilities
 
$
180,712

 
 
 
Total cash price paid upon acquisition
 
$
186,699

BMS [Member]  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
Below is a summary which details the purchase price allocation of assets acquired as a result of this acquisition:

 
 
 
Assets Acquired:
 
(in thousands)
Product license
 
$
32,000

Option
 
62,000

Goodwill
 
21,000

Total Assets
 
$
115,000

Total cash price paid upon acquisition
 
$
115,000

 
 
 
ProFibrix [Member]  
Business Acquisition [Line Items]  
Schedule of Business Acquisitions, by Acquisition
Total purchase price is summarized as follows:
 
 
(in thousands)
Upfront cash consideration
 
$
105,395

Fair value of contingent purchase price
 
82,550

Total purchase price
 
$
187,945

 
 
 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
Below is a summary which details the allocation of assets acquired and liabilities assumed as a result of this acquisition:
 
 
 
Assets Acquired:
 
(in thousands)
Cash
 
$
7,880

Prepaid assets
 
528

Fixed assets, net
 
124

In-process research and development
 
176,000

Goodwill
 
52,037

Total Assets
 
$
236,569

Liabilities Assumed:
 
 
Accounts payable
 
$
1,074

Accrued expenses
 
3,544

Contingent purchase price
 
82,550

Deferred tax liabilities
 
44,006

Total Liabilities
 
$
131,174

 
 
 
Total cash price paid upon acquisition
 
$
105,395

Rempex [Member]  
Business Acquisition [Line Items]  
Schedule of Business Acquisitions, by Acquisition
Total purchase price is summarized as follows:
 
 
(in thousands)
Upfront cash consideration
 
$
140,251

Fair value of contingent cash payment
 
96,700

Total purchase price
 
$
236,951

 
 
 

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
Below is a summary which details the allocation of assets acquired and liabilities assumed as a result of this acquisition:
 
 
 
Assets Acquired:
 
(In thousands)
Cash and cash equivalents
 
$
4,218

Accounts receivable, net
 
399

Inventory
 
566

Prepaid expenses and other current assets
 
2,465

Fixed assets, net
 
331

Intangible assets
 
530

In-process research and development
 
224,680

Goodwill
 
68,632

Total Assets
 
301,821

Liabilities Assumed:
 
 
Accounts payable
 
1,413

Accrued expenses
 
5,867

Deferred tax liabilities
 
57,590

Total Liabilities
 
64,870

 
 
 
Total purchase price
 
$
236,951

 
 
 
Tenaxis Medical [Member]  
Business Acquisition [Line Items]  
Schedule of Business Acquisitions, by Acquisition
Total purchase price is summarized as follows:
 
 
 
(In thousands)
Upfront cash consideration
 
 
$
58,871

Fair value of contingent purchase price
 
 
37,900

Total purchase price
 
 
$
96,771

 
 
 
 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
Below is a summary which details the allocation of assets acquired and liabilities assumed as a result of this acquisition:

Assets Acquired:
 
 
(In thousands)
 
 
 
 
Cash and cash equivalents
 
 
$
914

Inventory
 
 
307

Developed product rights
 
 
93,900

Goodwill
 
 
25,063

Other assets
 
 
131

Total assets
 
 
$
120,315

 
 
 
 
Liabilities assumed:
 
 
 
 
 
 
 
Accounts payable
 
 
161

Contingent purchase price
 
 
37,900

Deferred tax liability
 
 
23,160

Other liabilities
 
 
223

Total liabilities
 
 
$
61,444

 
 
 
 
Total cash price paid upon acquisition
 
 
$
58,871